M Ventures
M Ventures invests in innovative technologies and products with the potential to significantly impact Merck‘s core business areas.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed M Ventures Information
Geographic Data
Address: Gustav Mahlerplein 102 Toyo lto Building
City: Amsterdam
State: noord-holland
Zip: 1082 MA
Country: NL
Financial Info
Stage:
Raised Last:
$0
Raised Total:$677M
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
8,401,931Website Global Rank
315Website Monthly Traffic
Twitter Followers
Description
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 4/2009 | Ambrx | Series D | 10M |
| 2/2019 | Calypso Biotech | Series A | 22.7M |
| 9/2021 | Calypso Biotech | Series A | 0 |
| 6/2009 | Anaphore | Series A | 13M |
| 1/2022 | Future Fertility | Series A | - |
| 4/2019 | Sonde Health | Series A | 0 |
| 10/2017 | Peratech | Equity | 12.4M |
| 3/2014 | Bird Rock Bio | Series B | 0 |
| 1/2020 | iOnctura | Series A | 16.6M |
| 2/2021 | Metalenz | Series A | 10M |
| 2/2014 | Synaffix BV | Series A | - |
| 9/2021 | Legendairy Foods | Series A | 0 |
| 1/2012 | Galecto | Seed Round | - |
| 4/2013 | Canbex Therapeutics | Venture Round | 3.2M |
| 6/2023 | Celestial AI | Series B | 100M |
| 8/2018 | ApoGen Biotechnologies | Series A | 4M |
| 11/2017 | Wiliot | Series A | 5M |
| 3/2017 | Medisafe | Series B | 0 |
| 9/2020 | NanoSyrinx | Pre Seed Round | - |
| 1/2017 | ARTSaVIT | Series A | 6.3M |
| 7/2021 | Wiliot | Series C | 0 |
| 11/2021 | Biolinq | Series B | 0 |
| 1/2017 | Macrophage Pharma | Series A | 0 |
| 11/2020 | F-Star Therapeutics | Post-IPO Equity | 0 |
| 5/2018 | Gamelynx | Equity | 1.2M |
| 8/2021 | Immunitas Therapeutics | Series B | 0 |
| 7/2020 | iOnctura | Series A | 5.8M |
| 10/2018 | Galecto | Series C | 90.2M |
| 2/2017 | Prexton Therapeutics | Series B | 31.1M |
| 7/2019 | Forendo Pharma | Venture Round | 0 |
| 8/2018 | Vantage Point | Pre Seed Round | 1.4M |
| 3/2022 | Concerto Biosciences | Equity | 24.5M |
| 11/2021 | NeoLogic (VLSI) | Seed Round | 2.8M |
| 7/2021 | Artios Pharma | Series C | 0 |
| 6/2017 | Indi Molecular | Series A | 0 |
| 5/2020 | SynSense | Series A | - |
| 5/2019 | Storm Therapeutics | Series A | 17.8M |
| 9/2016 | Artios Pharma | Series A | 0 |
| 7/2021 | NanoSyrinx | Seed Round | 8.5M |
| 2/2018 | FanAI | Venture Round | 0 |
| 11/2018 | curbFlow | Seed Round | - |
| 7/2020 | DNA Script | Series B | 50M |
| 8/2018 | Vantage Point | Pre Seed Round | 0 |
| 9/2017 | DNA Script | Series A | 13.2M |
| 12/2022 | Storm Therapeutics | Series B | 30M |
| 11/2020 | Ferroelectric Memory Company | Series B | 0 |
| 10/2013 | Galecto | Series B | 6.3M |
| 2/2015 | Prexton Therapeutics | Series A | 10M |
| 1/2012 | Translate Bio | Series A | 20.7M |
| 10/2021 | DNA Script | Series C | 0 |
| 7/2016 | Akili Interactive Labs | Series B | 42.4M |
| 10/2017 | aveni | Series B | 10.5M |
| 11/2018 | Ribometrix | Series A | 30M |
| 7/2018 | Mosa Meat | Series A | 0 |
| 3/2022 | Concerto Biosciences | Series A | 24.5M |
| 12/2019 | Neurable | Series A | 6M |
| 2/2022 | Celestial AI | Series A | 56M |
| 7/2015 | Translate Bio | Series B | 0 |
| 4/2011 | F-Star Therapeutics | Venture Round | 0 |
| 6/2018 | Mighty Bear Games | Seed Round | 2.5M |
| 9/2020 | Tipe | Seed Round | 2.1M |
| 1/2021 | Theolytics | Series A | 6.8M |
| 10/2014 | Forendo Pharma | Series A | 0 |
| 6/2018 | Inthera Bioscience | Series A | 0 |
| 10/2022 | Nucleome Therapeutics | Series A | 42.3M |
| 10/2013 | F-Star Therapeutics | Series A | 0 |
| 3/2023 | PxE | Seed Round | 0 |
| 2/2022 | Micropsi Industries | Series B | 0 |
| 3/2019 | Biolinq | Series A | 4.8M |
| 11/2017 | Biolinq | Series A | 0 |
| 6/2020 | Micropsi Industries | Series A | - |
| 5/2009 | Bird Rock Bio | Series A | 13M |
| 1/2010 | F-Star Therapeutics | Series A | 11.5M |
| 5/2021 | Soteria Biotherapeutics | Series A | 42M |
| 7/2019 | SIMULATE | Seed Round | 7M |
| 1/2018 | Rewind Therapeutics | Series A | 18.3M |
| 10/2014 | Raze Therapeutics | Series A | 24M |
| 1/2023 | Rewind Therapeutics | Series A | - |
| 2/2020 | Scipio Bioscience | Series A | 6.5M |
| 4/2020 | FoRx Therapeutics | Seed Round | 10.8M |
| 6/2016 | Storm Therapeutics | Series A | 16M |
| 4/2016 | Metabomed | Series A | 18M |
| 2/2018 | FanAI | Seed Round | 2.5M |
| 2/2022 | Plexium | Series B | 0 |
| 10/2022 | Metalenz | Series B | 0 |
| 4/2021 | Anavo Therapeutics | Seed Round | 0 |
| 9/2020 | SeeQC | Series A | 22.4M |
| 3/2022 | Altoida | Series A | 0 |
| 9/2018 | Forendo Pharma | Venture Round | 0 |
| 5/2017 | Inthera Bioscience | Series A | 0 |
| 3/2020 | Xilio Therapeutics | Series B | 100.5M |
| 9/2016 | IOmx Therapeutics | Series A | 44.6M |
| 10/2021 | IOmx Therapeutics | Series B | 0 |
| 7/2016 | Progyny | Series B | 14.7M |
| 2/2021 | Medisafe | Series C | 0 |
| 6/2023 | Astraveus | Seed Round | 0 |
| 5/2018 | Akili Interactive Labs | Series C | 0 |
| 5/2021 | Akili Interactive Labs | Series D | 0 |
| 1/2023 | Rewind Therapeutics | Series B | - |
| 5/2019 | Altoida | Series A | 6.3M |
| 11/2015 | ObsEva | Series B | 58.9M |
| 11/2019 | ResoTher Pharma | Seed Round | 2.4M |
| 8/2017 | Alcan Systems | Series A | 8.8M |
| 12/2022 | Sonde Health | Series B | 19.3M |
| 5/2022 | PictorLabs | Series A | 0 |
| 9/2020 | Mosa Meat | Series B | 0 |
| 5/2021 | MemryX | Series A | - |
| 9/2015 | Asceneuron | Series A | 30.8M |
| 2/2023 | UNISERS | Seed Round | 14M |
| 4/2014 | Padlock Therapeutics | Series A | 14.7M |
| 3/2013 | Calypso Biotech | Seed Round | 3.3M |
| 6/2017 | iOnctura | Seed Round | - |
| 3/2022 | Altoida | Series A | 0 |
| 2/2022 | Plexium | Series B | 0 |
| 2/2022 | Micropsi Industries | Series B | 0 |
| 2/2022 | Celestial AI | Series A | 0 |
| 1/2022 | Future Fertility | Series A | - |
| 11/2021 | NeoLogic (VLSI) | Seed Round | 0 |
| 11/2021 | Biolinq | Series B | 0 |
| 10/2021 | DNA Script | Series C | 0 |
| 10/2021 | IOmx Therapeutics | Series B | 0 |
| 9/2021 | Legendairy Foods | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
